Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / tcr2 therapeutics tc 210 successful in mid stage can

TCRR - TCR2 Therapeutics' TC-210 successful in mid-stage cancer study

TCR2 Therapeutics Inc.
  • TCR2 Therapeutics (NASDAQ:TCRR) announces positive interim data from the first five patients treated in the Phase 1 portion of the TC-210 Phase 1/2 trial for mesothelin-expressing solid tumors.
  • More news on: TCR2 Therapeutics Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: TCR2 Therapeutics Inc.
Stock Symbol: TCRR
Market: NYSE
Website: tcr2.com
Menu
TCRR TCRR Quote TCRR Short TCRR News TCRR Articles TCRR Message Board
Get TCRR Alerts

News, Short Squeeze, Breakout and More Instantly...